Package 31722-316-31

{"route": ["ORAL"], "spl_id": "27e377c2-1e6a-d4e2-e063-6394a90a2812", "openfda": {"nui": ["N0000175550", "N0000175625", "N0000175624", "N0000175605", "N0000175076"], "upc": ["0331722316606"], "unii": ["W36ZG6FT64"], "rxcui": ["314230"], "spl_set_id": ["80269e86-3b04-44d0-9bff-7e7129e8ccb3"], "pharm_class_pe": ["Decreased Immunologic Activity [PE]"], "pharm_class_epc": ["mTOR Inhibitor Immunosuppressant [EPC]", "Kinase Inhibitor [EPC]"], "pharm_class_moa": ["mTOR Inhibitors [MoA]", "Protein Kinase Inhibitors [MoA]"], "manufacturer_name": ["Camber Pharmaceuticals, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 CARTON in 1 KIT (31722-316-31)  / 1 BOTTLE, GLASS in 1 CARTON (31722-316-60)  / 60 mL in 1 BOTTLE, GLASS", "package_ndc": "31722-316-31", "marketing_start_date": "20240916"}], "brand_name": "SIROLIMUS", "product_id": "31722-316_27e377c2-1e6a-d4e2-e063-6394a90a2812", "dosage_form": "SOLUTION", "pharm_class": ["Decreased Immunologic Activity [PE]", "Kinase Inhibitor [EPC]", "Protein Kinase Inhibitors [MoA]", "mTOR Inhibitor Immunosuppressant [EPC]", "mTOR Inhibitors [MoA]"], "product_ndc": "31722-316", "generic_name": "Sirolimus", "labeler_name": "Camber Pharmaceuticals, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "SIROLIMUS", "active_ingredients": [{"name": "SIROLIMUS", "strength": "1 mg/mL"}], "application_number": "ANDA215080", "marketing_category": "ANDA", "marketing_start_date": "20240916", "listing_expiration_date": "20261231"}